Brand Name: AFANAT 40
Product Name: Afatinib Dimaleate 40 MG
|Package Size : each bottle contain 28 tablets
Discerption :Afatinib dimaleate is a drug that belongs to the class of tyrosine kinase inhibitors, specifically targeting the epidermal growth factor receptor (EGFR). It is used in the treatment of certain types of advanced non-small cell lung cancer (NSCLC) and metastatic breast cancer. Afatinib works by blocking specific proteins involved in the growth and spread of cancer cells.
As an irreversible inhibitor of EGFR, afatinib dimaleate helps to inhibit signaling pathways that promote uncontrolled cell growth. This targeted therapy is particularly relevant for patients whose tumors have specific EGFR mutations. Afatinib dimaleate is typically prescribed under medical supervision, and its use may be associated with certain side effects, so patients are carefully monitored during treatment.
It’s important for individuals prescribed afatinib dimaleate to follow their healthcare provider’s guidance, report any side effects promptly, and attend regular check-ups to monitor the effectiveness of the treatment. As with any medication, discussions about potential benefits and risks should be thoroughly addressed between the patient and their healthcare team.